ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04724	Glutamatergic synapse	33/235	152/7206	8.71309678099e-19
ko05033	Nicotine addiction	19/235	56/7206	3.99807207988e-15
ko04713	Circadian entrainment	23/235	136/7206	5.34107108451e-11
ko04723	Retrograde endocannabinoid signaling	26/235	175/7206	5.70151385336e-11
ko04728	Dopaminergic synapse	26/235	185/7206	2.02543697931e-10
ko04727	GABAergic synapse	18/235	110/7206	1.25337760647e-08
ko05031	Amphetamine addiction	16/235	91/7206	2.89771494543e-08
ko05032	Morphine addiction	17/235	110/7206	7.75230520197e-08
ko04720	Long-term potentiation	16/235	99/7206	9.96376473547e-08
ko05030	Cocaine addiction	13/235	73/7206	5.13726908958e-07
ko04911	Insulin secretion	16/235	117/7206	1.05046573448e-06
ko04024	cAMP signaling pathway	26/235	279/7206	1.10490805331e-06
ko04721	Synaptic vesicle cycle	13/235	80/7206	1.53182323554e-06
ko04261	Adrenergic signaling in cardiomyocytes	21/235	205/7206	2.8428749757e-06
ko04020	Calcium signaling pathway	24/235	265/7206	4.85364599536e-06
ko04080	Neuroactive ligand-receptor interaction	32/235	423/7206	6.50215574541e-06
ko04921	Oxytocin signaling pathway	20/235	209/7206	1.38711542512e-05
ko05014	Amyotrophic lateral sclerosis (ALS)	10/235	74/7206	0.000129015645964
ko04725	Cholinergic synapse	15/235	160/7206	0.000213108500019
ko04022	cGMP-PKG signaling pathway	18/235	216/7206	0.000226354574921
ko04970	Salivary secretion	11/235	95/7206	0.000244463987407
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	9/235	79/7206	0.00100766848811
ko05414	Dilated cardiomyopathy	11/235	112/7206	0.00101013847426
ko04915	Estrogen signaling pathway	12/235	131/7206	0.00111859568234
ko05203	Viral carcinogenesis	1/235	277/7206	0.00159293216546
ko04924	Renin secretion	9/235	86/7206	0.00184833545392
ko00513	Various types of N-glycan biosynthesis	6/235	42/7206	0.00221169387209
ko05034	Alcoholism	17/235	238/7206	0.00224074946389
ko04730	Long-term depression	8/235	78/7206	0.00372068205211
ko04740	Olfactory transduction	8/235	80/7206	0.00435110231385
ko04726	Serotonergic synapse	11/235	137/7206	0.00499875866129
ko04010	MAPK signaling pathway	20/235	321/7206	0.00537336264969
ko00510	N-Glycan biosynthesis	6/235	50/7206	0.00539600777814
ko04072	Phospholipase D signaling pathway	14/235	197/7206	0.00626789862087
ko04925	Aldosterone synthesis and secretion	9/235	105/7206	0.00708592131336
ko04514	Cell adhesion molecules (CAMs)	10/235	130/7206	0.0097765126025
ko04972	Pancreatic secretion	9/235	111/7206	0.0100756767691
ko04070	Phosphatidylinositol signaling system	9/235	112/7206	0.010654512463
ko00512	Mucin type O-glycan biosynthesis	4/235	29/7206	0.0137947560005
ko04015	Rap1 signaling pathway	17/235	278/7206	0.0139684214362
ko04742	Taste transduction	6/235	61/7206	0.0140278645654
ko04260	Cardiac muscle contraction	8/235	98/7206	0.0143510468235
ko04371	Apelin signaling pathway	12/235	177/7206	0.0154043177127
ko05410	Hypertrophic cardiomyopathy (HCM)	8/235	100/7206	0.0160602278636
ko04012	ErbB signaling pathway	8/235	109/7206	0.0256022801698
ko00562	Inositol phosphate metabolism	7/235	89/7206	0.0256858743356
ko04962	Vasopressin-regulated water reabsorption	5/235	58/7206	0.0399225396992
ko04722	Neurotrophin signaling pathway	10/235	160/7206	0.0407102621125
ko05214	Glioma	6/235	79/7206	0.0435006581002
ko00515	Mannose type O-glycan biosynthesis	3/235	25/7206	0.0464318077623
ko04114	Oocyte meiosis	9/235	139/7206	0.0470792340229